EGFR and neoplasm: This previous study demonstrated that, in tumors displaying epidermal growth factor receptor (EGFR) amplification, the FAP+ perivascular population lacked EGFR amplification, thereby identifying them as a stromal cell type rather than a subtype of tumor cells residing in the perivascular niche.